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jP-02.009jPrenatal immune challenge causes frontal-subcortical
proteome changes relevant to schizophrenia and
autism
M. Deng1, U. Meyer2, S. Lam3, J. Feldon2, Q. Li3, R. Wei3, L. Luk3,
S. Chua3, P. Sham3, Y. Wang3, G. McAlonan3. 1Hong Kong, Hong Kong
SAR, China ; 2Schwerzenbach, Switzerland ; 3University Of Hong Kong,
Hong Kong SAR, China
Objective : Maternal immune activation (MIA) during prenatal life
increases risk of neurodevelopmental disorders including schizo-
phrenia and autism. Schizophrenia and autism cause alterations in
fronto-striatal circuits, but the molecular basis is unclear. In this study
we experimentally tested the impact of MIA on adult prefrontal and
striatal proteome.
Methods : A conventional MIA mouse model, generated by ad-
ministering the viral analogue PolyI :C or saline (control) intra-
venously on gestation day 9, was adopted. Striatal and prefrontal
cortex (PFC) proteomes of 4 male and 3 female MIA and control adult
mice were compared using advanced 2-dimensional diﬀerential in-gel
electrophoresis (2D-DIGE).
Results : In striatum, around 1500 spots were detected by DeCyder
Diﬀerential In-gel Analysis (DIA) module. After standard protein ex-
clusion ﬁltering, around 1300 spots were included for Biological
Variation Analysis (BVA). In PFC around 1800 spots were detected
and 1300 spots were included for BVA module. Independent Student
t-tests revealed that in the striatum, 11 spots showed up-regulation
and 4 spots showed down-regulation in polyI :C group. Nine protein
spots were identiﬁed by MALDI-TOF mass spectrometry. In polyI :C
PFC region, 10 spots were up-regulated, 7 spots down-regulated and
9 identiﬁed by MALDI-TOF mass spectrometry. The expression of
proteins altered in PolyI :C mice included dual speciﬁcity mitogen-
activated protein kinase kinase 1 (MEK), eukaryotic initiation factor
(eIF) 4A-II, creatine kinase (CK)-B, L-lactate dehydrogenase (LDH)-B,
WD repeat-containing protein and NADH dehydrogenase in the
striatum ; and guanine nucleotide-binding protein (G-protein), 14-3-3
protein zeta/delta (KCIP-1), alpha-enolase, olfactory maker protein
and heat shock protein (HSP)60, and 90-beta in the PFC.
Conclusion : The present data ﬁts with emerging evidence that key
components of critical converging intracellular pathways including
MAPK, PTEN, mTOR and FMRP are altered in neurodevelopmental
conditions which may open fresh avenues for capturing biomarkers
and novel treatment targets for neurodevelopmental conditions.
Policy of full disclosure : None.
jP-02.010jAntidepressant-like eﬀect of phytoestrogen daidzein
in ovariectomized rats in the forced swimming test
J. Fedotova1, N. Ordyan1. 1 Institute of Physiology RASci, St. Petersburg,
Russia
Objective : Numerous reports demonstrate the potency of phyto-
estrogens to ameliorate physical and emotional alterations in ovarian
dysfunction and permanent absence of ovarian hormones (DAnna
et al., 2007). The aim of the present study was to determine the anti-
depressant-like eﬀects of diﬀerent doses of phytoestrogen daidzein in
the ovariectomized (OVX) rats submitted to the forced swimming test
(FST), and its eﬀect was compared with a clinically eﬀective anti-
depressant, clomipramine.
Methods : OVX female Wistar rats were used in all experiments.
Two weeks later after surgery rats were treated with vehicle, daidzein
(0,1, 0,5 and 1,0 mg/kg, i.p.) or clomipramine (50.0 mg/kg, i.p.)
chronically for 14 days before the forced swimming test (FST) and
open ﬁeld test (OFT). Immediately after the FST and OFT, hormonal
assay for estradiol (E2) and follitropine (FSH) levels in the blood was
performed. The data wee analyzed by one-way ANOVA with
Dunnett’s post-hoc test.
Results : In the FST, daidzein (0.5 and 1.0 mg/kg) and clomipra-
mine signiﬁcantly decreased immobility behavior in OVX females as
compared to the control group (p<0.05). In addition, daidzein failed
to change swimming time or struggling time in the OVX rats in the
FST. In the OFT, daidzein (0.5 and 1.0 mg/kg) increased frequency of
rearing and duration of grooming as compared to the control group
(p<0.05). The hormonal assay results demonstrated the increased E2
levels and decreased FSH levels in the blood in the group treated with
daidzein as compared with OVX rats. The results of this study provide
evidence that phytoestrogen daidzein exerts antidepressant-like eﬀect
in rats with deﬁciency of ovarian hormones in the FST.
Conclusion : In conclusion, phytoestrogen daidzein produces anti-
depressant-eﬀect in female rats with absence of ovarian hormones in
the FST, supporting the hypotheses that phytoestrogens could be used
to ameliorate depression associated with ovarian dysfunction or
menopause.
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jP-02.011jSynergistic interaction between prenatal immune
challenge and peri-pubertal stress in the disruption
of adult behavioral functions relevant to
schizophrenia
J. Feldon1, S. Giovanoli2, U. Meyer2. 1ETH Zurich, Lab. of Behav.
Neurobiology, Schwerzenbach, Switzerland ; 2ETH Zurich, Schwerzenbach,
Switzerland
Objective : Converging evidence from human epidemiological stu-
dies and parallel experimental investigations in animals indicates that
prenatal exposure to infection may be a relevant environmental risk
factor for schizophrenia and related disorders. However, if prenatal
infection does indeed play a signiﬁcant role in the etiology of schizo-
phrenia, then it likely does so by interacting with other genetic and/or
environmental susceptibility factors. Besides prenatal infection, ex-
posure to stressful situations in peri-pubertal stages of life has been
repeatedly suggested to represent a signiﬁcant postnatal environ-
mental factor in the development of psychotic disorders. Against this
background, the present study was designed to test the hypothesis
whether prenatal viral-like immune challenge may synergistically in-
teract with peri-pubertal stress to facilitate the emergence of schizo-
phrenia-like behavioral abnormalities in adulthood.
Methods : We combined a well established mouse model of pre-
natal (gestation day 9) immune challenge by the viral mimic Poly[I :C]
with a model of exposure to peri-pubertal stress induced by a 5-days
variable stress protocol applied in peri-puberty (postnatal days 30 to
35).
Results : We found that peri-pubertal stress led to signiﬁcant im-
pairments in sensorimotor gating in the form of prepulse inhibition
(PPI) disruption and blunted exploratory activity in a novel environ-
ment speciﬁcally in animals which had been subjected to prenatal
Poly[I :C]-induced immune challenge at low intensity (1 mg/kg, i.v).
Neither prenatal Poly[I :C] treatment at the chosen dose alone nor
peri-pubertal stress alone induced such behavioral abnormalities.
Conclusion : Our ﬁndings support the biological plausibility for
synergistic interactions between prenatal immune challenge and
postnatal stress in the precipitation of brain dysfunctions relevant to
schizophrenia. In accordance with an environmental two-hit model of
schizophrenia etiology, prenatal immune challenge may render the
brain more vulnerable to postnatal stress, thereby facilitating the de-
velopment of full-blown psychotic disturbances associated with
schizophrenia.
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jP-02.012j Inositol transporter knockout mice show a lithium-
like phenotype in the amphetamine-induced
hyperactivity paradigm
I. Hadas1, L. Toker1, Y. Askira1, R.H. Belmaker1, G. Agam1,
Y. Bersudsky1. 1Ben Gurion University, Beersheva, Israel
Objective : Lithium (Li), the drug of choice in bipolar disorder, re-
duces the function of the sodium-myo-inositol cotransporter (SMIT)1
and was shown to decrease brain myo-inositol levels in rodents.
Reduction in brain myo-inositol was also found in SMIT1 knockout
mice (1). Homozygous but not heterozygous SMIT1 knockout mice
were shown to exhibit lithium-like behavior in the pilocarpine-in-
duced seizure paradigm and the forced swimming test (1). In rodents,
chronic Li treatment results in reduced amphetamine-induced hy-
peractivity (2). 1)Agam G, Bersudsky Y, Berry GT, Moechars D, Lavi-
Avnon Y, Belmaker RH. Biochem Soc Trans. 2009. 2) Gould TD,
O’Donnell KC, Picchini AM, Manji HK. Neuropsychopharmacology
32 : 1321-33, 2007.
Methods : SMIT1 homozygous knockout male mice, 2.5–4.5 month
old (n=19) and their wildtype littermates (n=26) were placed
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